Dental anxiety treatment by a dentist in primary care: A 1-year follow-up study.

cognitive behavioural therapy health communication midazolam randomized controlled trial

Journal

European journal of oral sciences
ISSN: 1600-0722
Titre abrégé: Eur J Oral Sci
Pays: England
ID NLM: 9504563

Informations de publication

Date de publication:
08 2022
Historique:
received: 21 01 2022
accepted: 29 04 2022
pubmed: 16 5 2022
medline: 2 8 2022
entrez: 15 5 2022
Statut: ppublish

Résumé

In an earlier randomized controlled trial of dental anxiety treatments (n = 96) we compared the effects of dentist-administered cognitive behavioural therapy (D-CBT) and dental treatment supplemented with the Four Habits communication model plus midazolam sedation. Both treatments, applied in a general dental practice, were associated with a clinically relevant decrease in dental anxiety. In this follow-up study, 52 of the 82 treatment completers responded to an online questionnaire 1 year post-treatment. Reduction in dental anxiety persisted for both treatment groups. From baseline to 1 year post-treatment the Modified Dental Anxiety Scale was reduced by 7.8 [SD: 4.4; Cohen's d effect size: 1.2 (CI: 0.8-1.7)] and 7.8 [SD: 4.2; Cohen's d: 1.4 (0.9-1.8)] in the D-CBT and Four Habits/midazolam groups, respectively. Most patients (74% for D-CBT, 80% for Four Habits/midazolam) continued with dental treatment. Nine patients in the D-CBT and seven in the Four Habits/midazolam groups received additional CBT treatment from a psychologist/dentist team. Both methods tested should be accessible to interested dentists who receive adequate training. Effective first-line treatments for dental anxiety in general dental practice can generate more accessible care pathways for patients with dental anxiety. Evidence-based dental anxiety treatment programmes should be included in the dental curriculum and established as best practice for dentists.

Identifiants

pubmed: 35569119
doi: 10.1111/eos.12872
pmc: PMC9540184
doi:

Substances chimiques

Midazolam R60L0SM5BC

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12872

Informations de copyright

© 2022 Scandinavian Division of the International Association for Dental Research. Published by John Wiley & Sons Ltd.

Références

Acta Odontol Scand. 2020 Jan;78(1):13-19
pubmed: 31287346
Eur J Oral Sci. 2021 Dec;129(6):e12820
pubmed: 34448277
Community Dent Oral Epidemiol. 2004 Aug;32(4):250-64
pubmed: 15239776
Stat Surv. 2010;4:1-39
pubmed: 20414472
J Clin Psychol. 2009 Jul;65(7):755-68
pubmed: 19437509
Community Dent Health. 2016 Jun;33(2):121-6
pubmed: 27352466
Br Dent J. 2011 Aug 26;211(4):159-62
pubmed: 21869789
Eur J Oral Sci. 2011 Oct;119(5):373-80
pubmed: 21896054
Psychol Assess. 2010 Jun;22(2):279-87
pubmed: 20528055
Acta Odontol Scand. 2003 Apr;61(2):93-9
pubmed: 12790506
Eur J Oral Sci. 2022 Aug;130(4):e12872
pubmed: 35569119
Eur J Oral Sci. 2015 Dec;123(6):453-9
pubmed: 26607209
Eur J Oral Sci. 2021 Aug;129(4):e12794
pubmed: 33960536
Community Dent Oral Epidemiol. 2013 Jun;41(3):279-87
pubmed: 23004917
SAAD Dig. 2007 Jan;23:29-34
pubmed: 17265912
Community Dent Health. 1988 Mar;5(1):3-18
pubmed: 3285972
J Med Pract Manage. 2001 Jan-Feb;16(4):184-91
pubmed: 11317576
Eur J Oral Sci. 2005 Aug;113(4):289-96
pubmed: 16048520
BMC Oral Health. 2007 Jan 14;7:1
pubmed: 17222356
Community Dent Oral Epidemiol. 2008 Oct;36(5):409-16
pubmed: 18924257
Br Dent J. 2007 Dec 8;203(11):629-31
pubmed: 18065980
J Public Health Dent. 2015 Winter;75(1):64-73
pubmed: 25234823
Community Dent Oral Epidemiol. 2000 Dec;28(6):435-42
pubmed: 11106016
Br J Oral Maxillofac Surg. 2000 Dec;38(6):612-616
pubmed: 11092778
Community Dent Health. 1995 Sep;12(3):143-50
pubmed: 7584581
Eur J Oral Sci. 2020 Oct;128(5):423-428
pubmed: 33463781
Acta Odontol Scand. 2010 Nov;68(6):335-43
pubmed: 20831356
J Pharm Bioallied Sci. 2015 Aug;7(Suppl 2):S414-9
pubmed: 26538889
Anesth Prog. 1993;40(3):72-7
pubmed: 7645792
BMC Oral Health. 2014 May 31;14:59
pubmed: 24884798
Int Dent J. 2019 Feb;69(1):44-49
pubmed: 30028019
J Consult Clin Psychol. 2000 Jun;68(3):378-87
pubmed: 10883554
Acta Odontol Scand. 2001 Oct;59(5):290-6
pubmed: 11680648

Auteurs

Mariann Saanum Hauge (MS)

Faculty of Dentistry, University, of Oslo, Oslo, Norway.
Oral Health Centre of Expertise, Rogaland, Stavanger, Norway.

Bent Stora (B)

Oral Health Services Agder, Kristiansand, Norway.

Tiril Willumsen (T)

Faculty of Dentistry, University, of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH